Decreased ceramide underlies mitochondrial dysfunction in Charcot-Marie-Tooth 2F

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Charcot-Marie-Tooth (CMT) disease is a common inherited neurologic disorder with unclear molecular mechanisms.
• Mutations in heat shock protein 27 (Hsp27) are linked to CMT type 2F.
• Sphingolipid dysregulation is implicated in neurodegenerative diseases.

Purpose of the Study:

• To investigate the role of bioactive sphingolipid dysregulation in CMT.
• To determine how Hsp27 mutations affect ceramide metabolism and mitochondrial function.

Main Methods:

• Analysis of Hsp27 knockout mice and disease-associated Hsp27 mutants.
• Assessment of ceramide levels in peripheral nerve and mitochondrial fractions.
• Examination of ceramide synthase (CerS) localization and activity.
• Mitochondrial morphology and function assays (respiratory function, autophagic flux).
• Pharmacological inhibition of ceramide generation.

Main Results:

• Hsp27 knockout mice showed decreased peripheral nerve ceramide.
• Hsp27 S135F mutant demonstrated reduced mitochondrial ceramide levels.
• Mutant Hsp27 led to decreased CerS1 mitochondrial localization, not activity.
• Mutant cells exhibited altered mitochondrial structure (larger, more interconnected) and function (decreased respiration, increased autophagy).
• Pharmacological ceramide reduction mimicked these mitochondrial changes.

Conclusions:

• Mutant Hsp27 impairs mitochondrial ceramide homeostasis.
• Reduced mitochondrial ceramide contributes to mitochondrial dysfunction and neuronal degeneration in CMT 2F.
• Hsp27 chaperone activity is critical for maintaining mitochondrial ceramide levels and function.